Alzheimer’s disease Archive — Page 1 of 7

August 5, 2026

Team’s AI agent to speed Alzheimer’s treatment

Patients who qualify for new Alzheimer’s disease therapies often wait weeks before receiving a first infusion.

By Paul Govern
(iStock)
August 4, 2026

Lower cardiac output predicts faster brain loss in carriers of Alzheimer’s disease risk gene

The study followed 756 participants over an 11-year period and examined whether reduced cardiac function could lead to adverse brain health outcomes even in the absence of cardiovascular disease.

By Misa Acox
(iStock)
July 3, 2026

Vanderbilt Center for Cognitive Medicine seeks participants for trial evaluating Alzheimer’s disease-related psychosis treatment

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.

By Danny Bonvissuto
April 7, 2026

Multi-institutional team pioneers retinal test for early Alzheimer’s disease

The potential for a retinal screening test was bolstered by a recent discovery that clearance of amyloid-beta oligomers by immune cells in retinal blood vessels was disrupted in donor eyes from individuals with Alzheimer’s disease, compared to age-matched, healthy control eyes.

By Bill Snyder
March 18, 2026

Vanderbilt Center for Cognitive Medicine enrolls first Down syndrome participant for Alzheimer’s disease study

Evan Dewey and his family travel from Atlanta to participate in the ABATE study, a clinical trial evaluating a treatment that could reduce the likelihood of Alzheimer’s disease development in individuals with Down syndrome

By Danny Bonvissuto
February 24, 2026

Study identifies medical conditions that could predict future Alzheimer’s disease

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

By Leigh MacMillan